Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Recruiting
Observational Study
Endometrial Carcinoma (EC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 – 80
- Sex
- Female
- Study type
- Observational
- Participants needed
- 3,100 (estimated)
- Sponsor
- National Cancer Institute, Naples · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study involves the use of reagents or materials for diagnostic assessments that are not commercially available, specifically a metabolomic signature for screening endometrial carcinoma and/or other types of cancers, and follows a case-control design.
This study aims to achieve several objectives that contribute to evaluating the diagnostic potential of a specific "metabolomic signature" to be…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Female sex
2. Age between 50 and 80 years
3. Willingness to participate in the study and signing of the informed consent
4. Clinical condition of post-menopause
Exclusion Criteria:
1. Previous hysterectomy
2. Hormone replacement therapy
3. Immunosuppressive therapy
Contacts